First-Line Treatment of Schizophrenia: Are Children and Adolescents Really Benefiting from Newer, More Frequently Prescribed Second Generation Antipsychotics

Authors

F. Ellen Loh, Touro College of PharmacyFollow

Document Type

Presentation

Publication Date

4-25-2018

Recommended Citation

Loh, F. E., Khan, I., & Azzi, B. (2018, April 25). First-line treatment of schizophrenia: Are children and adolescents really benefiting from newer, more frequently prescribed second generation antipsychotics? Presentation at the Academy of Managed Care Pharmacy Annual Meeting, Boston, Massachusetts.